The global nerve repair and regeneration market size reached USD 9.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 22.2 Billion by 2033, exhibiting a growth rate (CAGR) of 9.45% during 2025-2033.
Nerve repair and regeneration (NRaR) refers to a neural tissue engineering process used for the treatment of a nerve injury. It facilitates the regrowth of new neurons, glial cells, myelin, axons and synapses. It also aids in restoring the normal functioning of the nerve after nerve damage, which is usually caused by pressure, blunt trauma, stretching or cutting of a nerve. NRaR involves the use of biomaterials and various neuro-stimulation and neuromodulation devices. Biomaterials include nerve conduits, nerve protectors, nerve wraps, and nerve connectors. They are used for direct neuropathy, nerve grafting, stem cell therapy and transcutaneous, transcranial magnetic, spinal cord, deep brain, sacral nerve and vagus nerve stimulation.
Nerve Repair and Regeneration Market Trends:
The increasing prevalence of chronic neurological disorders, such as Alzheimer's, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis and multiple system atrophy, is among the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, and escalating instances of nerve injuries are providing a thrust to the growth of the market. Hospitals, ambulatory surgical centers (ASCs) and other healthcare institutes across the globe are providing novel NRaR solutions for timely diagnosis and treatment of neurological disorders. Additionally, various technological advancements in stem cell therapy and the development of innovative neuromodulation devices, are acting as other growth-inducing factors. Endogenous stem cells are being widely used in neurogenesis, neural repair and exogenous neural stem cell transplantation for effective repair and replacement of damaged tissues in the central nervous system. Other factors, including rising healthcare expenditures of the masses, along with the significant improvements in the medical infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.
Key Market Segmentation:
Breakup by Surgery:
Direct Nerve Repair/Neurorrhaphy
Nerve Grafting
Stem Cell Therapy
Neurostimulation and Neuromodulation Surgeries
Breakup by Product:
Biomaterial
Neurostimulation and Neuromodulation Devices
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation Devices
Vagus Nerve Stimulation Devices
Gastric Electric Stimulation Devices
Breakup by End User:
Hospitals and Clinics
Ambulatory Surgical Centers
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global nerve repair and regeneration market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:
Abbott Laboratories
Alafair Biosciences Inc.
AxoGen Inc.
Baxter International Inc.
Boston Scientific Corporation
Collagen Matrix Inc
Integra Lifesciences Corporation
Medtronic plc
Polyganics BV
Soterix Medical Inc.
Stryker Corporation
Synapse Biomedical Inc.
Key Questions Answered in This Report
1.What was the size of the global nerve repair and regeneration market in 2024?
2.What is the expected growth rate of the global nerve repair and regeneration market during 2025-2033?
3.What are the key factors driving the global nerve repair and regeneration market?
4.What has been the impact of COVID-19 on the global nerve repair and regeneration market?
5.What is the breakup of the global nerve repair and regeneration market based on the surgery?
6.What is the breakup of the global nerve repair and regeneration market based on the product?
7.What is the breakup of the global nerve repair and regeneration market based on the end user?
8.What are the key regions in the global nerve repair and regeneration market?
9.Who are the key players/companies in the global nerve repair and regeneration market?
Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Nerve Repair and Regeneration Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Surgery
6.1 Direct Nerve Repair/Neurorrhaphy
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Nerve Grafting
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Stem Cell Therapy
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Neurostimulation and Neuromodulation Surgeries